EFPIA Newsletter 25 June 2020

#WeWontRest in the fight against COVID-19

Our latest statements     22 June 2020 Time to step up investments in health systems: EFPIA statement on the EU4Health Programme The COVID crisis has shown us the close link between health and wealth. This is the time to step up health investments... Read more →         22 June 2020 Preparing for a potential second COVID-19 wave Joint statement by Medicines for Europe and EFPIA with A.T. Kearney Read more →         19 June 2020 COVID-19 and Brexit - Protecting patients across Europe from pandemics A group of 18 pan-European healthcare stakeholders launched the statement “COVID-19 and Brexit – Protecting patients... Read more →

Blogs

EFPIA members' efforts against COVID-19

	Janssen Theresa Pattery thanks all the volunteers that have joined hands to test for Covid-19 diagnostics on the Janssen campus in Beerse, helping to make a big difference for all those patients out there , for the hospitals and clinics.		Pfizer UK The COVID-19 pandemic has had a profound impact on everyone in the UK, separating us from our loved ones and taking thousands of lives. Yet, even while battling this devastating disease, the acts of so many individuals have shown us to be a more caring and generous nation than perhaps we even knew.

	Pfizer Russia Pfizer Russia supports the Russian healthcare system through monetary support for hospitals treating COVID-19 patients, donations of medicines, and securing extra support for COVID-19 related matters for charity funds		Sanofi & GSK Sanofi and GSK joined forces in unprecedented vaccine collaboration to fight COVID-19. Listen to Dr Thomas Breuer, Senior Vice President, Chief Medical Officer, GSK Vaccines, and Dr Su-Peing Ng, Global Medical Head, Sanofi Pasteur, as they explain why their companies are putting energy and expertise together to help be part of the solution.

Did you miss our latest #EFPIATalks? Watch them again!     11 JUN 2020   Diabetes and COVID-19: when two pandemics meet - Integrated care Virtual event Rethinking health systems: integrated care and empowerment of primary care Learn more →       15 JUN 2020   Diabetes and COVID-19: when two pandemics meet: digital health Virtual event Engage, define, track, measure, improve: the potential of the digital transformation in diabetes care Learn more →

	09 JUN 2020			United in the search of a COVID-19 vaccine Virtual event The first of a series of virtual events dedicated on COVID-19 vaccines and pandemic preparedness Learn more →

	19 MAY 2020			Clinical Trials at the time of COVID-19: And beyond? Virtual event On the occasion of International Clinical Trials Day on 20 May, this event seeks to explore the lessons learnt from... Learn more →

What we are reading First COVID-19 treatment recommended for EU authorisation 25 June 2020  (EMA website) Read more → Meet the woman shaping the future of the European Medicines Agency 25 June 2020  (Politico) Read more → IMI launches final IMI2 Calls for proposals 23 June 2020  (IMI website) Read more → Coronavirus: Using European supercomputing, EU-funded research project announces promising... 18 June 2020  (European Commission) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe